Preview

User

Not a user? Register with this site Forgot your password?

Cardiovascular Therapy and Prevention

Advanced search

Proportion of COVID-19 survivors in 2020-2022 in the Russian population (according to the ESSE-RF3 study)

https://doi.org/10.15829/1728-8800-2023-3852

EDN: XVAWIQ

Abstract

Aim. To study the proportion of coronavirus disease 2019 (COVID-19) survivors and hospitalization cases of the Russian population for the period 2020-2022, depending on socio-demographic characteristics.

Material and methods. The work was performed on random samples of the population aged 35-74 years from 15 regions participating in the Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation-3 (ESSE-RF3) study. The examination was carried out from February 2020 to March-April 2022 (n=28718, 47% men).

Results. According to a survey of sample participants, the proportion of respondents who had COVID-19 by the spring of 2022 among all surveyed was 26,0%. Among 45-54-year-old respondents, this parameter was maximum (28,0%), while among those aged 65-74-year-old — minimal (22,3%). The following categories of people were more likely to have COVID-19: women (27,9 vs 23,9% of men, p<0,001), persons with higher education (30 vs 22,6% persons without higher education, p<0,001), persons with high income (30,0 vs 24,3% low-income, p=0,002), persons with family (26,6 vs 24,8% single, p<0,001), employed persons (28,4 vs 21,7% non-employed, p<0,001), as well as those living in urban areas (26,5 vs 24,5% country people, p=0,003). But those less likely to have COVID-19 (men, people without higher education, low-income, single, unemployed or rural residents) had more severe disease course. The following categories of people had higher hospitalization rates: men (26,0 vs 20,9% women, p<0,001), patients without higher education (27,1 vs 19,6% those with higher education, p<0,001), non-employed (34,3 vs 18,4% workers), p<0,001) and rural residents (27,2 vs 22,0% of city residents, p<0,001). Hospitalization rate was not associated with the level of income and marital status. However, low-income and single people were more likely to require mechanical ventilation.

Conclusion. The results obtained by survey reflect the following population data: the proportion of patients after COVID-19, hospitalization rate and the development of severe acute respiratory failure requiring mechanical ventilation among Russians for the period 2020-2022. This can complement the population data demonstrated by state statistics. Special attention from the healthcare system, both during treatment and prevention of COVID-19, requires males, people aged ≥65 years, low-income people, single people (widowers, divorced), unemployed people (pensioners, disabled people, nonemployed), rural residents and people without higher education.

About the Authors

G. A. Muromtseva
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


S. A. Shalnova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


V. A. Kutsenko
National Medical Research Center for Therapy and Preventive Medicine; Lomonosov Moscow State University
Russian Federation

Moscow


E. M. Filichkina
National Medical Research Center for Therapy and Preventive Medicine; Lomonosov Moscow State University
Russian Federation

Moscow


Yu. A. Balanova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


S. E. Evstifeeva
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


A. E. Imaeva
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


A. V. Kapustina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


N. S. Karamnova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


M. B. Kotova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


S. A. Maksimov
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


O. B. Shvabskaya
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


O. E. Ivlev
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


A. A. Zelenina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


L. I. Gomanova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


E. B. Yarovaya
National Medical Research Center for Therapy and Preventive Medicine; Lomonosov Moscow State University
Russian Federation

Moscow


A. V. Kontsevaya
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


T. V. Repkina
Regional Center for Public Health and Medical Prevention
Russian Federation

Barnaul


T. O. Gonoshilova
Regional Center for Public Health and Medical Prevention
Russian Federation

Barnaul


A. V. Kudryavtsev
Northern State Medical University
Russian Federation

Arkhangelsk


N. I. Belova
Northern State Medical University
Russian Federation

Arkhangelsk


L. L. Shagrov
Northern State Medical University
Russian Federation

Arkhangelsk


M. A. Samotrueva
Astrakhan State Medical University
Russian Federation

Astrakhan


A. L. Yasenyavskaya
Astrakhan State Medical University
Russian Federation

Astrakhan


Z. N. Chernysheva
Astrakhan State Medical University
Russian Federation

Astrakhan


S. V. Glukhovskaya
Sverdlovsk Regional Medical College
Russian Federation

Ekaterinburg


I. A. Levina
Sverdlovsk Regional Medical College
Russian Federation

Ekaterinburg


E. A. Shirshova
Sverdlovsk Regional Medical College
Russian Federation

Ekaterinburg


E. B. Dorzhieva
Boyanov Center for Public Health and Medical Prevention.
Russian Federation

Ulan-Ude


E. Z. Urbanova
Boyanov Center for Public Health and Medical Prevention.
Russian Federation

Ulan-Ude


N. Yu. Borovkova
Privolzhsky Research Medical University
Russian Federation

Nizhny Novgorod


V. K. Kurashin
Privolzhsky Research Medical University
Russian Federation

Nizhny Novgorod


A. S. Tokareva
Privolzhsky Research Medical University
Russian Federation

Nizhny Novgorod


Yu. I. Ragino
Research Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and Genetics
Russian Federation

Novosibirsk


G. I. Simonova
Research Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and Genetics
Russian Federation

Novosibirsk


A. D. Khudyakova
Research Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and Genetics
Russian Federation

Novosibirsk


V. N. Nikulin
Orenburg Regional Center for Public Health and Medical Prevention
Russian Federation

Orenburg


O. R. Aslyamov
Orenburg Regional Center for Public Health and Medical Prevention
Russian Federation

Orenburg


G. V. Khokhlova
Orenburg Regional Center for Public Health and Medical Prevention
Russian Federation

Orenburg


A. V. Solovyova
Tver State Medical University
Russian Federation

Tver


A. A. Rodionov
Tver State Medical University
Russian Federation

Tver


O. V. Kryachkova
Tver State Medical University
Russian Federation

Tver


Yu. Yu. Shamurova
South Ural State Medical University
Russian Federation

Chelyabinsk


i. V. Tantsyreva
South Ural State Medical University
Russian Federation

Chelyabinsk


I. N. Baryshnikova
South Ural State Medical University
Russian Federation

Chelyabinsk


M. G. Ataev
Abusuev Research Institute of Environmental Medicine, Dagestan State Medical University
Russian Federation

Makhachkala


M. O. Radzhabov
Abusuev Research Institute of Environmental Medicine, Dagestan State Medical University
Russian Federation

Makhachkala


M. M. Isakhanova
Abusuev Research Institute of Environmental Medicine, Dagestan State Medical University
Russian Federation

Makhachkala


M. A. Umetov
Berbekov Kabardino-Balkarian State University
Russian Federation

Nalchik


L. V. Elgarova
Berbekov Kabardino-Balkarian State University
Russian Federation

Nalchik


I. A. Khakuasheva
Berbekov Kabardino-Balkarian State University
Russian Federation

Nalchik


E. I. Yamashkina
Ogarev Mordovian State University
Russian Federation

Saransk


M. V. Esina
Ogarev Mordovian State University
Russian Federation

Saransk


T. A. Kunyaeva
Ogarev Mordovian State University; Mordovian Republican Central Clinical Hospital
Russian Federation

Saransk


A. M. Nikitina
Republican Center for Public Health and Medical Prevention
Russian Federation

Yakutsk


N. V. Savvina
Ammosov North-Eastern Federal University
Russian Federation

Yakutsk


Yu. E. Spiridonova
Republican Center for Public Health and Medical Prevention
Russian Federation

Yakutsk


E. A. Naumova
Republican Center for Public Health and Medical Prevention, Exercise therapy and Sports Medicine
Russian Federation

Cheboksary


A. A. Keskinov
Center for Strategic Planning and Management of Biomedical Health Risks
Russian Federation

Moscow


V. S. Yudin
Center for Strategic Planning and Management of Biomedical Health Risks
Russian Federation

Moscow


S. M. Yudin
Center for Strategic Planning and Management of Biomedical Health Risks
Russian Federation

Moscow


D. A. Kashtanova
Center for Strategic Planning and Management of Biomedical Health Risks
Russian Federation

Moscow


M. S. Gusakova
Center for Strategic Planning and Management of Biomedical Health Risks
Russian Federation

Moscow


O. M. Drapkina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow


References

1. Karpova LS, Stolyarov KA, Popovtseva NM, et al. Comparison of the first three waves of the COVID-19 pandemic in Russia (2020-2021). Epidemiology and Vaccine Prevention. 2022;21(2):4-16. (In Russ.) doi:10.31631/2073-3046-2022-21-2-4-16.

2. Soeorg H, Jõgi P, Naaber P, et al. Seroprevalence and levels of IgG antibodies after COVID-19 infection or vaccination. Infect Dis. 2022;54:1;63-71. doi:10.1080/23744235.2021.1974540.

3. Perkhov VI, Korkhmazov VT, Hodakova OB. Influence of the pandemic of COVID-19 on indicators of incidence of the population. Current problems of health care and medical statistics. 2022;4:588-609. (In Russ.) doi:10.24412/2312-2935-2022-4-588-609.

4. López-Gay A, Spijker J, Cole HVS, et al. Sociodemographic determinants of intraurban variations in COVID-19 incidence: the case of Barcelona. J Epidemiol Community Health. 2022;76(1):1-7. doi:10.1136/jech-2020-216325.

5. Vasenev SL. The influence of socio-economic factors on the spread of the COVID pandemic in the regions of the Russian Federation. Fundamental Research. 2021;4:17-23. (In Russ.) doi: 10.17513/fr.42994.

6. Kong JD, Tekwa EW, Gignoux-Wolfsohn SA. Social, economic, and environmental factors influencing the basic reproduction number of COVID-19 across countries. PLoS One. 2021;16(6):e0252373. doi:10.1371/journal.pone.0252373.

7. Hradsky O, Komarek A. Demographic and public health characteristics explain large part of variability in COVID-19 mortality across countries. Eur J Public Health. 2021;31(1):12-6. doi:10.1093/eurpub/ckaa226.

8. Tikunov VS, Belozerov VS, Shchitova NA, et al. Spatial analysis of the spread of COVID-19 and its demographic consequences in the regions of southern European Russia. Population and economy. 2022;6(4):189-208. (In Russ.) doi:10.3897/popecon.6.e97380.

9. Birenbaum-Carmeli D, Chassida J. Health and socio-demographic implications of the Covid-19 second pandemic wave in Israel, compared with the first wave. Int J Equity Health. 2021;20:154. doi:10.1186/s12939-021-01445-y.

10. Levin AT, Owusu-Boaitey N, Pugh S, et al. Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications. BMJ Global Health. 2022;7:e008477. doi:10.1136/bmjgh-2022-008477.

11. Goutte S, Péran T, Porcher T. The role of economic structural factors in determining pandemic mortality rates: Evidence from the COVID-19 outbreak in France. Res Int Bus Finance. 2020;54:101281. doi:10.1016/j.ribaf.2020.101281.

12. Kalabikhina IE. Demographic and social issues of the pandemic. Population and Economics. 2020;4(2):103-22. (In Russ.) doi:10.3897/popecon.4.e53891.

13. Krieger E, Sharashova E, Kudryavtsev A, et al. COVID-19: seroprevalence and adherence to preventive measures in Arkhangelsk, Northwest Russia. Infect Dis. 2023;55(5):316-27. doi:10.1080/23744235.2023.2179660.

14. Klein S, Flanagan K. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626-38. doi:10.1038/nri.2016.90.

15. Redondo-Sendino A, Guallar-Castillόn P, Banegas JR, et al. Gender differences in the utilization of health-care services among the older adult population of Spain. BMC Public Health. 2006;6:155. doi:10.1186/1471-2458-6-155.

16. Wang Y, Jiao Y, Nie J, et al. Sex differences in the association between marital status and the risk of cardiovascular, cancer, and all-cause mortality: a systematic review and meta-analysis of 7,881,040 individuals. Glob Health Res Policy. 2020;5:4. doi:10.1186/s41256-020-00133-8.

17. Evstifeeva SE, Shalnova SА, Deev АD, et al. Diabetes risk and associations with demographic and behavioral factors in russian population: data from the ESSE-RF study. Russian Journal of Cardiology. 2017;(9):13-20. (In Russ.) doi:10.15829/1560-4071-2017-9-13-20.

18. Balanova YuA, Imaeva AE, Kutsenko VA, et al. Metabolic syndrome and its associations with socio-demographic and behavioral risk factors in the Russian population aged 25-64 years. Cardiovascular Therapy and Prevention. 2020;19(4):2600. (In Russ.) doi:10.15829/1728-8800-2020-2600.


Supplementary files

What is already known about the subject?

  • The proportion of coronavirus disease 2019 (COVID-19) survivors in the population and its as­sociations with the socio-­demographic charac­teristics have not been fully studied.

What might this study add?

  • The results obtained demonstrate the proportion of respondents who had COVID-19 by the spring of 2022, hospitalization rate and the need for mechanical ventilation, taking into account socio-­demographic factors.
  • The following categories of the population requiring special attention from the health care system during treatment and prevention (primary and secondary) of COVID-19 have been confirmed: males, persons >65 years old, low-income, single, unemployed, rural residents and persons without higher edu­cation.

Review

For citations:

Muromtseva G.A., Shalnova S.A., Kutsenko V.A., Filichkina E.M., Balanova Yu.A., Evstifeeva S.E., Imaeva A.E., Kapustina A.V., Karamnova N.S., Kotova M.B., Maksimov S.A., Shvabskaya O.B., Ivlev O.E., Zelenina A.A., Gomanova L.I., Yarovaya E.B., Kontsevaya A.V., Repkina T.V., Gonoshilova T.O., Kudryavtsev A.V., Belova N.I., Shagrov L.L., Samotrueva M.A., Yasenyavskaya A.L., Chernysheva Z.N., Glukhovskaya S.V., Levina I.A., Shirshova E.A., Dorzhieva E.B., Urbanova E.Z., Borovkova N.Yu., Kurashin V.K., Tokareva A.S., Ragino Yu.I., Simonova G.I., Khudyakova A.D., Nikulin V.N., Aslyamov O.R., Khokhlova G.V., Solovyova A.V., Rodionov A.A., Kryachkova O.V., Shamurova Yu.Yu., Tantsyreva i.V., Baryshnikova I.N., Ataev M.G., Radzhabov M.O., Isakhanova M.M., Umetov M.A., Elgarova L.V., Khakuasheva I.A., Yamashkina E.I., Esina M.V., Kunyaeva T.A., Nikitina A.M., Savvina N.V., Spiridonova Yu.E., Naumova E.A., Keskinov A.A., Yudin V.S., Yudin S.M., Kashtanova D.A., Gusakova M.S., Drapkina O.M. Proportion of COVID-19 survivors in 2020-2022 in the Russian population (according to the ESSE-RF3 study). Cardiovascular Therapy and Prevention. 2023;22(8S):3852. (In Russ.) https://doi.org/10.15829/1728-8800-2023-3852. EDN: XVAWIQ

Views: 611


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)

101000, Moscow, Petroverigsky per., 10, str. 3
National medical research center for therapy and preventive medicine

Тел: +7 (499) 553 67 78

Editorial office Cardiovascular Therapy and Prevention

supported by NEICON (Elpub lab)